Impaired facial emotion recognition abilities in HIVþ patients are well documented, but little is known about the neural etiology of these difficulties. We examined the relation of facial emotion recognition abilities to regional brain volumes in 44 HIV-positive (HIV þ ) and 44 HIV-negative control (HC) adults. Volumes of structures implicated in HIV-associated neuropathology and emotion recognition were measured on MRI using an automated segmentation tool. Relative to HC, HIVþ patients demonstrated emotion recognition impairments for fearful expressions, reduced anterior cingulate cortex (ACC) volumes, and increased amygdala volumes. In the HIV þ group, fear recognition impairments correlated significantly with ACC, but not amygdala volumes. ACC reductions were also associated with lower nadir CD4 levels (i.e., greater HIV-disease severity). These findings extend our understanding of the neurobiological substrates underlying an essential social function, facial emotion recognition, in HIVþ individuals and implicate HIV-related ACC atrophy in the impairment of these abilities.
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Introduction
Several studies have reported reduced facial emotion recognition abilities in disorders that, like HIV infection (Clark and Cohen, 2010) , are associated with frontostriatal dysfunction. Impairments have been noted in individuals with Parkinson's disease (Clark et al., 2008; Devlin et al., 2010; Dujardin et al., 2004; Lawrence et al., 2007; Sprengelmeyer et al., 2003 ), Huntington's disease (Johnson et al., 2007; Sprengelmeyer et al., 1996) , obsessive compulsive disorder (Sprengelmeyer et al., 1997), and HIV (Clark et al., 2010a) . Facial emotion recognition is a core component of the human experience (Darwin, 1872 (Darwin, /1965 . Accordingly, deficits in facial emotion recognition have been tied to increased interpersonal problems in a number of patient groups (Clark et al., 2008; Kornreich et al., 2002) , including HIV (Clark et al., 2010a) .
Despite a clear link between facial emotion recognition abilities and quality of life metrics in HIVþ individuals (Clark et al., 2010a), except for a handful of studies (Baldonero et al., 2013; Clark et al., 2010a; Heilman et al., 2013; Lane et al., 2012) , facial emotion recognition impairments in HIV þ cohorts have received little investigation. Results from these studies have been somewhat varied, with most reports indicating that HIV þ patients demonstrate impairments in recognizing negative emotions (Lane et al., 2012) , particularly fear (Baldonero et al., 2013; Clark et al., 2010a) , and one indicating that facial emotion recognition impairments are non-specific (Heilman et al., 2013) .
With only a few studies on the topic to date (Schulte et al., 2012) , there is a dearth of information regarding the neural etiologies of emotion processing abnormalities in HIV þ patients. Improved understanding of the neural correlates of these functions in HIV þ individuals would contribute both to our general understanding of HIV-associated neuropathology in relation to neuropsychiatric functions, and to our ability to properly conceptualize and treat these impairments. An important question relating to neuropsychiatric symptoms in HIVþ patients, which has yet to be answered fully, is whether affective difficulties have a purely neurologic or more psychogenic origin. Resolution of this 
